Nimodipine

Category: pharmacological

Aliases: Nimotop

Pharmacological Mechanism

Highly lipophilic dihydropyridine CCB — preferential cerebrovascular vasodilation. FDA-approved for prevention of vasospasm-related neurologic deficits after subarachnoid hemorrhage. Hypotension at high doses limits use.

Half-Life (t½)

PO: 2.9h

Dosing Guidelines

• PO: Typical 60mg (Range: 60 - 60 mg)

Target Organ Systems

• cardiovascular